A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer’s Disease
Condition(s):Early Alzheimer’s DiseaseLast Updated:March 13, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Early Alzheimer’s DiseaseLast Updated:March 13, 2024Recruiting
Condition(s):Preclinical Alzheimer’s Disease; Early Preclinical Alzheimer’s DiseaseLast Updated:February 8, 2024Recruiting
Condition(s):Down Syndrome; Alzheimer Disease; DementiaLast Updated:March 7, 2024Recruiting
Condition(s):Agitation; DementiaLast Updated:March 27, 2024Recruiting
Condition(s):Preclinical Alzheimer’s Disease; Prodromal Alzheimer’s Disease; Alzheimer Disease; DementiaLast Updated:March 28, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.